Video

Dr. Nabors on Evolving Treatment Options for Brain Metastases

Louis B. Nabors, MD, of University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases.

Louis B. Nabors, MD, professor, University of Alabama, Birmingham Comprehensive Cancer Center, discusses the evolving treatment landscape for patients with brain metastases. For decades, as treatment for patients with brain metastases, physicians mainly relied on neurosurgery and radiation, and there were limited systemic therapy options.

Today, there is an increasing amount of systemic therapy options, says Nabors. These therapies have clearly demonstrated activity in metastatic disease in the central nervous system, he adds.

Research continues to focus on further developing these opportunities to better understand how to deploy systemic therapies in these patients. This will be a major goal over the next several years, he concludes.

<<< 2019 NCCN Annual Meeting

Related Videos
Sheldon M. Feldman, MD
Rita Mukhtar, MD
Lajos Pusztai, MD, DPhil
Hope S. Rugo, MD
Karl Semaan, MD, MSc
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.
Toni K. Choueiri, MD
Neil J. Shah, MBBS
Sujith Samarasinghe, MD
Suzanne Trudel, MSc, MD